These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36404638)

  • 21. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
    Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-neutrophil Cytoplasmic Antibody-negative Eosinophilic Granulomatosis with Polyangiitis Complicated with Peripheral Neuropathy that Underwent Remission Induction with Mepolizumab Monotherapy.
    Nishihara M; Suzuki M; Asatani S; Nagasawa Y; Tsukamoto M; Akiya K; Kobayashi H; Kitamura N; Nakamura H
    Intern Med; 2023 Oct; 62(19):2895-2900. PubMed ID: 36725044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
    Hellmich B; Holle J; Moosig F
    Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
    Koike H; Nishi R; Yagi S; Furukawa S; Fukami Y; Iijima M; Katsuno M
    Adv Ther; 2023 Jan; 40(1):25-40. PubMed ID: 36152266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review.
    Kamide Y; Watai K; Nakamura Y; Iwata M; Fukutomi Y; Taniguchi M; Sekiya K
    Allergol Int; 2024 Jan; 73(1):180-183. PubMed ID: 37852914
    [No Abstract]   [Full Text] [Related]  

  • 27. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    McBrien CN; Menzies-Gow A
    Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Uematsu H; Takata S; Sueishi K; Inoue H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Steroids-Resistant EGPA-Induced Neuropathy with Acute Disease Progression: How to Use Mepolizumab as Novel Targeted Agent].
    Hattori N
    Brain Nerve; 2022 May; 74(5):531-536. PubMed ID: 35589643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Gilyarov MY; Belikova LP; Shchukin IA; Fidler MS; Avakyan GG; Shustrova GE; Martynov MY; Svet AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):93-102. PubMed ID: 28635862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    Ennis D; Lee JK; Pagnoux C
    Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.
    Belfeki N; Abroug S; Ghriss N; Chouchane I; Hamrouni S; Strazzulla A; Zayet S
    Clin Exp Rheumatol; 2021 Oct; 40(4):834-837. PubMed ID: 35522541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mepolizumab and Eosinophilic Pleural Effusion in Patient With Eosinophilic Granulomatosis With Polyangiitis.
    Lorenzo Martínez MDC; Clavería García O; Herrero Mendoza MD; Jareño Esteban JJ
    Arch Bronconeumol; 2023 Jul; 59(7):439-440. PubMed ID: 37059683
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Moosig F; Holle J
    Z Rheumatol; 2019 May; 78(4):333-338. PubMed ID: 30627842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates for the treatment of EGPA.
    Raffray L; Guillevin L
    Presse Med; 2020 Oct; 49(3):104036. PubMed ID: 32652104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature.
    Kai M; Vion PA; Boussouar S; Cacoub P; Saadoun D; Le Joncour A
    RMD Open; 2023 Sep; 9(3):. PubMed ID: 37673442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
    Carrette A; Mercier V; Lelubre C; Peché R
    Rev Mal Respir; 2022 Sep; 39(7):621-625. PubMed ID: 35909008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review.
    Kouverianos I; Angelopoulos A; Daoussis D
    Rheumatol Int; 2023 Jul; 43(7):1245-1252. PubMed ID: 37085573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L; Guillevin L
    Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis.
    Chang HC; Chou PC; Lai CY; Tsai HH
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):445-452.e6. PubMed ID: 32771687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.